Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NYSE:EVGN)

8.82
Delayed Data
As of 4:01pm ET
 -0.04 / -0.45%
Today’s Change
8.07
Today|||52-Week Range
14.14
-4.23%
Year-to-Date

Today’s Trading

Previous close8.86
Today’s open8.82
Day’s range8.79 - 8.86
Volume1,500
Average volume (3 months)6,073
Market cap$225.0M
Dividend yield--
Data as of 4:01pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)-28.89%
Earnings growth (this year)-21.19%
Earnings growth (next 5 years)--
Revenue growth (last year)-17.46%
P/E ratio--
Price/Sales16.06
Price/Book1.93

Competitors

 Today’s
change
Today’s
% change
IKNXIkonics Corp-0.01-0.07%
CCMPCabot Microelectroni...-0.46-1.01%
OCIPOCI Partners LP-0.55-3.38%
KYTHKYTHERA Biopharmaceu...+0.02+0.03%
Data as of 4:02pm ET, 08/03/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$14.5M
Annual profit (last year)-$14.5M
Net profit margin-100.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Financial Officer
Sigal Fattal
Corporate headquarters
Rehovot, Tel Aviv

Forecasts